RxDoctor Payments Data

Larry Johnson, MD

Adult Reconstructive Orthopaedic Surgery · Jackson, TNNPI 1053410662

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $38,075 of the $55,422 with a category attached, or 68.7%. Smith+Nephew accounts for 99.1% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $20,652 and has fallen 92.0% since, to $1,645 in 2025.

$55,422in general payments, 2019–2025

Across 102 payments — averaging $543.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$55K
  • Pacira Therapeutics, Inc.$109
  • Gentleman Orthopedic Solutions$75
  • Zimmer Biomet$71
  • Orthofix Medical, Inc.$38
  • Convatec Inc.$35
  • plus $189 from 9 others

What the payments were for

  • Consulting fees$1,9504%
  • Speaking & faculty fees$38,07569%
  • Travel & lodging$12,58423%
  • Food & beverage$2,8145%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$55,422 in reported general payments places this provider in the 70th percentile of 27 adult reconstructive orthopaedic surgery providers in Tennessee.

See all adult reconstructive orthopaedic surgery providers in Tennessee

Medicare billing

Part B allowed, 2024
$321,980
Medicare patients
651
Services billed
24,190

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib104$1,611
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen183$1,364
Mupirocin99$716
Diclofenac Sodium61$654
Meloxicam184$484
Gabapentin104$373
Tramadol Hcl150$364
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen31$234
Hydroxyzine Hcl11$143
Amoxicillin33$22

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Jackson

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →